NAPROXEN

dominion pharmacal🇨🇦 Health Canada

Approval Id: 502d4fbb1af999d3
Drug Approval Canada Name: NAPROXEN
Product Name: NAPROXEN
Status: Cancelled Post Market
Status Date: 2020-05-06
Original Market Date: 2016-06-01
Din: 02408759
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: OTC
Ahfs: 28:08.04.92
Atc Original: M01AE02 NAPROXEN
Atc Name: m 01 ae 02
Aig Number: 0113934003
Company Name: dominion pharmacal
Company Address: SUITE 100, 6111, Avenue Royalmount, Montreal, Quebec, Canada, H4P 2T4

NAPROXEN SODIUM

220 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

502d4fbb1af999d3

Type

Standard